Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

P. B. McIntyre, C. S. Berkey, S. M. King, U. B. Schaad, T. Kilpi, G. Y. Kanra and C. M. Perez
Royal Alexandra Hospital for Children, Sydney, New South Wales, Australia.

OBJECTIVE: To evaluate the effectiveness of dexamethasone in bacterial meningitis in the subcategories of causative organism and timing and nature of antibiotic therapy. DATA SOURCES: MEDLINE, HEALTHLINE, and AIDSLINE were searched with the Medical Subject Headings "dexamethasone" and "meningitis" in any language. Bibliographies, conference abstracts, and the authors of identified studies were consulted. STUDY SELECTION: Randomized, concurrently controlled trials of dexamethasone therapy in childhood bacterial meningitis published from 1988 to November 1996 were selected. Of 16 studies identified, 5 were not eligible. DATA EXTRACTION: Data were extracted by means of standard outcomes in a protocol sent to all principal authors. DATA SYNTHESIS: Random-effects meta-analysis models were used to obtain summary estimates. As the incidence of severe hearing loss differed significantly by organism among control subjects, organism-specific estimates were used. In Haemophilus influenzae type b meningitis, dexamethasone reduced severe hearing loss overall (combined odds ratio [OR], 0.31; 95% confidence interval [CI], 0.14-0.69). Similar ORs were obtained after studies were stratified by the timing of administration of dexamethasone (before or with antibiotics vs later) or by type of antibiotic (cefuroxime vs other). In pneumococcal meningitis, only studies in which dexamethasone was given early suggested protection, which was significant for severe hearing loss (combined OR, 0.09; 95% CI, 0.0-0.71) and approached significance for any neurological or hearing deficit (combined OR, 0.23; 95% CI, 0.04-1.05). For all organisms combined, the pooled OR suggested protection against neurological deficits other than hearing loss but was not significant (OR, 0.59; 95% CI, 0.34-1.02). Outcomes were similar in studies that used 2 vs more than 2 days of dexamethasone therapy. Adverse effects were not significantly increased with dexamethasone except for secondary fever. The incidence of gastrointestinal tract bleeding increased with longer duration of dexamethasone treatment (0.5% in controls, 0.8% with 2 days of treatment, 3.0% with 4 days of treatment). CONCLUSIONS: The available evidence on adjunctive dexamethasone therapy confirms benefit for H influenzae type b meningitis and, if commenced with or before parenteral antibiotics, suggests benefit for pneumococcal meningitis in childhood. Limiting dexamethasone therapy to 2 days may be optimal.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mechanisms of Dexamethasone-Mediated Inhibition of Toll-Like Receptor Signaling Induced by Neisseria meningitidis and Streptococcus pneumoniae
Mogensen et al.
Infect. Immun. 2008;76:189-197.
ABSTRACT | FULL TEXT  

Corticosteroids for Bacterial Meningitis in Adults in Sub-Saharan Africa
Scarborough et al.
NEJM 2007;357:2441-2450.
ABSTRACT | FULL TEXT  

Corticosteroids for Acute Bacterial Meningitis
Greenwood
NEJM 2007;357:2507-2509.
FULL TEXT  

Steroids for bacterial meningitis in children?
DTB 2007;45:93-95.
ABSTRACT | FULL TEXT  

Dexamethasone as Adjuvant Therapy to Moxifloxacin Attenuates Valve Destruction in Experimental Aortic Valve Endocarditis Due to Staphylococcus aureus
Skiadas et al.
Antimicrob. Agents Chemother. 2007;51:2848-2854.
ABSTRACT | FULL TEXT  

Emergency management of meningococcal disease: eight years on
Pollard et al.
Arch. Dis. Child. 2007;92:283-286.
FULL TEXT  

VASCULAR ENDOTHELIAL GROWTH FACTOR IS ASSOCIATED WITH BLOOD BRAIN BARRIER DYSFUNCTION IN EOSINOPHILIC MENINGITIS CAUSED BY ANGIOSTRONGYLUS CANTONENSIS INFECTION
TSAI et al.
Am J Trop Med Hyg 2007;76:592-595.
ABSTRACT | FULL TEXT  

Radiology Quiz Case 1: Diagnosis
Arch Otolaryngol Head Neck Surg 2007;133:300-300.
FULL TEXT  

Treatment Leading to Dramatic Recovery in Acute Hemorrhagic Leukoencephalitis
Payne et al.
J Child Neurol 2007;22:109-113.
ABSTRACT  

A Single Dose of Dexamethasone To Prevent Postbronchoscopy Fever in Children: A Randomized Placebo-Controlled Trial
Picard et al.
Chest 2007;131:201-205.
ABSTRACT | FULL TEXT  

Early Vancomycin Therapy and Adverse Outcomes in Children With Pneumococcal Meningitis
Buckingham et al.
Pediatrics 2006;117:1688-1694.
ABSTRACT | FULL TEXT  

Improving the outcome of pneumococcal meningitis
Pelton and Yogev
Arch. Dis. Child. 2005;90:333-334.
FULL TEXT  

A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis
McIntyre et al.
Arch. Dis. Child. 2005;90:391-396.
ABSTRACT | FULL TEXT  

Central Nervous System Infections in the Critically Ill
Lewin et al.
Journal of Pharmacy Practice 2005;18:25-41.
ABSTRACT  

Acute Bacterial Meningitis in Children
Haase
Journal of Pharmacy Practice 2004;17:392-406.
ABSTRACT  

Review: adjuvant corticosteroid therapy reduces death, hearing loss, and neurological sequelae in bacterial meningitis
Morris
Evid. Based Med. 2004;9:48-48.
FULL TEXT  

Does early administration of dexamethasone improve neurological outcome in children with meningococcal meningitis?
Gupta and Tuladhar
Arch. Dis. Child. 2004;89:82-83.
FULL TEXT  

Hearing Loss at School Age in Survivors of Bacterial Meningitis: Assessment, Incidence, and Prediction
Koomen et al.
Pediatrics 2003;112:1049-1053.
ABSTRACT | FULL TEXT  

Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis
Lutsar et al.
J Antimicrob Chemother 2003;52:651-655.
ABSTRACT | FULL TEXT  

Reprogramming the Host Response in Bacterial Meningitis: How Best To Improve Outcome?
van der Flier et al.
Clin. Microbiol. Rev. 2003;16:415-429.
ABSTRACT | FULL TEXT  

Treatment of meningococcal infection
Welch and Nadel
Arch. Dis. Child. 2003;88:608-614.
ABSTRACT | FULL TEXT  

Diagnosis and treatment of bacterial meningitis
El Bashir et al.
Arch. Dis. Child. 2003;88:615-620.
ABSTRACT | FULL TEXT  

Pneumococcal meningitis: antibiotics essential but insufficient
Davis and Greenlee
Brain 2003;126:1013-1014.
FULL TEXT  

Dexamethasone in adults with bacterial meningitis
Suh
CMAJ 2003;168:740-740.
FULL TEXT  

Dexamethasone in Adults with Bacterial Meningitis
de Gans et al.
NEJM 2002;347:1549-1556.
ABSTRACT | FULL TEXT  

Corticosteroids for Everyone with Meningitis?
Tunkel and Scheld
NEJM 2002;347:1613-1615.
FULL TEXT  

The emergence of resistant pneumococcal meningitis--implications for empiric therapy
McMaster et al.
Arch. Dis. Child. 2002;87:207-210.
ABSTRACT | FULL TEXT  

The management of croup
Brown
Br Med Bull 2002;61:189-202.
ABSTRACT | FULL TEXT  

Pneumococcal Meningitis in the Intensive Care Unit . Prognostic Factors of Clinical Outcome in a Series of 80 Cases
AUBURTIN et al.
Am. J. Respir. Crit. Care Med. 2002;165:713-717.
ABSTRACT | FULL TEXT  

Corticosteroid Supplementation for Adrenal Insufficiency
Coursin and Wood
JAMA 2002;287:236-240.
FULL TEXT  

Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis
Nau and Eiffert
Clin. Microbiol. Rev. 2002;15:95-110.
ABSTRACT | FULL TEXT  

Evidence of Less Severe Aortic Valve Destruction after Treatment of Experimental Staphylococcal Endocarditis with Vancomycin and Dexamethasone
Siaperas et al.
Antimicrob. Agents Chemother. 2001;45:3531-3537.
ABSTRACT | FULL TEXT  

Non-traumatic coma in children
Kirkham
Arch. Dis. Child. 2001;85:303-312.
FULL TEXT  

Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young Children
Lieu et al.
JAMA 2000;283:1460-1468.
ABSTRACT | FULL TEXT  

Matrix Metalloproteinases Contribute to Brain Damage in Experimental Pneumococcal Meningitis
Leib et al.
Infect. Immun. 2000;68:615-620.
ABSTRACT | FULL TEXT  

Glucocorticoids in Central Nervous System Bacterial Infection
Coyle
Arch Neurol 1999;56:796-801.
ABSTRACT | FULL TEXT  

Cerebral malaria versus bacterial meningitis in children with impaired consciousness
Berkley et al.
QJM 1999;92:151-157.
ABSTRACT | FULL TEXT  

Bacterial meningitis in adults: Demonstration of inner ear involvement using high-resolution MRI
Dichgans et al.
Neurology 1999;52:1003-1003.
ABSTRACT | FULL TEXT  

Emergency management of meningococcal disease
Pollard et al.
Arch. Dis. Child. 1999;80:290-296.
FULL TEXT  

Acute obstructive hydrocephalus complicating bacterial meningitis
Settle et al.
BMJ 1999;318:123b-123.
FULL TEXT  

Three-Year Multicenter Surveillance of Pneumococcal Meningitis in Children: Clinical Characteristics, and Outcome Related to Penicillin Susceptibility and Dexamethasone Use
Arditi et al.
Pediatrics 1998;102:1087-1097.
ABSTRACT | FULL TEXT  

Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae
Kaplan and Mason
Clin. Microbiol. Rev. 1998;11:628-644.
ABSTRACT | FULL TEXT  

Dexamethasone for Bacterial Meningitis
JWatch Emergency Med. 1997;1997:3-3.
FULL TEXT  

DEXAMETHASONE FOR BACTERIAL MENINGITIS
JWatch General 1997;1997:4-4.
FULL TEXT